Viewing Study NCT03410056


Ignite Creation Date: 2025-12-24 @ 11:20 PM
Ignite Modification Date: 2026-04-02 @ 6:47 AM
Study NCT ID: NCT03410056
Status: TERMINATED
Last Update Posted: 2021-06-22
First Post: 2018-01-03
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety and Efficacy of Efavaleukin Alfa in Subjects With Active Rheumatoid Arthritis
Sponsor: Amgen
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Rheumatoid Arthritis RA View
Keywords: